Gossamer Bio Inc $ 9.80 -0.14 (-1.41%)
Volume:
797,616
Avg Vol (1m):
657,182
Market Cap $:
744.09 Mil
Enterprise Value $:
415.20 Mil
PE Ratio:
0.00
PB Ratio:
2.25
Financial Strength | 4/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
Cash-To-Debt | 2.79 | ||
Debt-to-Equity | 0.57 | ||
Debt-to-EBITDA | -0.81 | ||
Piotroski F-Score | 3 | ||
Altman Z-Score | 0 | ||
Beneish M-Score | 0 | ||
WACC vs ROIC |
Profitability Rank | 1/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
ROE % | -68.67 | ||
ROA % | -47.78 | ||
ROC (Joel Greenblatt) % | -1435.06 | ||
3-Year EBITDA Growth Rate | -315.7 | ||
3-Year EPS without NRI Growth Rate | -68.7 |
GOSS
Valuation Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
PB Ratio | 2.25 | ||
EV-to-EBIT | -1.8 | ||
EV-to-EBITDA | -1.83 | ||
Current Ratio | 13.51 | ||
Quick Ratio | 13.51 |
Dividend & Buy Back |
Current | Vs Industry | Vs History | |
---|---|---|---|
3-Year Average Share Buyback Ratio | -40.3 |
Valuation & Return |
Current | Vs Industry | Vs History | |
---|---|---|---|
Price-to-Tangible-Book | 2.24 | ||
Earnings Yield (Greenblatt) % | -55.43 |